SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001628280-23-035952
Filing Date
2023-11-01
Accepted
2023-11-01 16:04:55
Documents
3
Period of Report
2023-11-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1698869085.html 3  
1 FORM 3 wk-form3_1698869085.xml 3 1612
2 EX-24.2 rayzebio-poax11x01x23.htm EX-24.2 3926
3 rayzebio-poax11x01x23001.jpg GRAPHIC 230457
  Complete submission text file 0001628280-23-035952.txt   324387
Mailing Address C/O ITEOS THERAPEUTICS, INC. 139 MAIN STREET CAMBRIDGE MA 02142
Business Address
Van Hauwermeiren Timothy (Reporting) CIK: 0001816206 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41799 | Film No.: 231368160

Mailing Address 5505 MOREHOUSE DRIVE, SUITE 300 SAN DIEGO CA 92121
Business Address 5505 MOREHOUSE DRIVE, SUITE 300 SAN DIEGO CA 92121 (619) 937-2754
RayzeBio, Inc. (Issuer) CIK: 0001825367 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations